Abortion-Related Mortality in the United States: 1998-2010

Obstetrics and Gynecology

Volumn 126, Issue 2, 2015, Pages 258-265

  Zane, Suzanne ^a   Creanga, Andreea A ^a   Berg, Cynthia J ^a   Pazol, Karen ^a   Suchdev, Danielle B ^a   Jamieson, Denise J ^a   Callaghan, William M ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; MIFEPRISTONE; MISOPROSTOL; PROSTAGLANDIN; SEDATIVE AGENT;

ABORTION; ADOLESCENT; ADULT; ANESTHESIA COMPLICATION; ARTICLE; BLEEDING; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CLOSTRIDIUM INFECTION; CLOSTRIDIUM PERFRINGENS; CLOSTRIDIUM SORDELLII; CURETTAGE; DILATION AND EVACUATION; DISEASE SEVERITY; DRUG FATALITY; EMBOLISM; FEMALE; GENERAL ANESTHESIA; GESTATIONAL AGE; HEALTH SURVEY; HIGH RISK PREGNANCY; HISPANIC; HUMAN; INDUCED ABORTION; LAMINARIA; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL MORTALITY; MEDICAL ABORTION; OBSTETRIC ANESTHESIA; PRIORITY JOURNAL; RACE; SEDATION; SURGICAL ABORTION; UNITED STATES; YOUNG ADULT; EPIDEMIOLOGY; ETHNIC GROUP; LEGAL ABORTION; MORTALITY; PREGNANCY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; UNPLANNED PREGNANCY;

ABORTION, LEGAL; ADULT; ETHNIC GROUPS; FEMALE; HUMANS; MATERNAL AGE; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY TRIMESTERS; PREGNANCY, UNPLANNED; RISK FACTORS; UNITED STATES;

EID: 84937693879     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000945     Document Type: Article

References (22)

1. Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health 2006;38:90-6.
2. Finer LB, Zolna MR. Shifts in intended and unintended pregnancies in the United States, 2001-2008. Am J Public Health 2014;104:S43-8.
3. Jones RK, Jerman J. Abortion incidence and service availability in the United States, 2011. Perspect Sex Reprod Health 2014; 46:3-14.
4. Pazol K, Creanga AA, Burley KD, Jamieson DJ; Centers for Disease Control and Prevention. Abortion surveillance-United States, 2011. MMWR Surveill Summ 2014;63:1-41.
5. Cates W, Grimes DA, Smith JC, Tyler CW. Legal abortion mortality in the United States: epidemiologic surveillance, 1972-74. JAMA 1977;237:452-5.
6. Atrash HK, MacKay HT, Binkin NJ, Hogue CJ. Legal abortion mortality in the United States: 1972 to 1982. Am J Obstet Gynecol 1987;156:605-12.
7. Lawson HW, Frye A, Atrash HK, Smith JC, Shulman HB, Ramick M. Abortion mortality, United States, 1972 through 1987. Am J Obstet Gynecol 1994;171:1365-72.
8. Bartlett LA, Berg CJ, Shulman HB, Zane SB, Green CA, Whitehead S, et al. Risk factors for legal induced abortionrelated mortality in the United States. Obstet Gynecol 2004; 103:729-37.
9. Creanga AA, Berg CJ, Syverson C, Seed K, Bruce FC, Callaghan WM. Pregnancy-related mortality in the United States, 2006-2010. Obstet Gynecol 2015;125:5-12.
10. Centers for Disease Control and Prevention. Pregnancy mortality surveillance in the United States. 2013. Available at: http://www.cdc.gov/reproductivehealth/MaternalInfantHealth/PregnancyrelatedMortality. htm. Retrieved November 16, 2014.
11. Jones RK, Darroch JE, Henshaw SK. Patterns in the socioeconomic characteristics of women obtaining abortions in 2000-2001. Perspect Sex Reprod Health 2002;34;226-35.
12. Jones RK, Kavanaugh ML. Changes in abortion rates between 2000 and 2008 and lifetime incidence of abortion. Obstet Gynecol 2011:117;1358-66.
13. Cantwell R, Clutton-Brock T, Cooper G, Dawson A, Drife J, Garrod D, et al. Saving mothers' lives: reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 2011;118: 1-203.
14. Creanga AA, Berg CJ, Syverson C, Seed K, Bruce C, Callaghan WM. Race, ethnicity and nativity differentials in pregnancy-related mortality in the United States: 1993-2006. Obstet Gynecol 2012;120:261-8.
15. Finer LB, Wei J. Effect of mifepristone on abortion access in the United States. Obstet Gynecol 2009;114:623-30.
16. Pazol K, Creanga AA, Zane SB. Trends in use of medical abortion in the United States: reanalysis of surveillance data from the centers for disease control and prevention, 2001-2008. Contraception 2012;86:746-51.
17. Fischer M, Bhatnagar J, Guarner J, Reagan S, Hacker JK, Van Meter SH, et al. Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion. N Engl J Med 2005;353:2352-60.
18. Cohen AL, Bhatnagar J, Reagan S, Zane SB, D'Angeli MA, Fischer M, et al. Toxic shock associated with Clostridium sordellii and Clostridium perfringens after medical and spontaneous abortion. Obstet Gynecol 2007;110:1027-33.
19. Meites E, Zane S, Gould G. Fatal Clostridium sordellii infections after medical abortions (correspondence). N Engl J Med 2010;363:1382-3.
20. Centers for Disease Control and Prevention. Clostridium sordellii toxic shock syndrome after medical abortion with mifepristone and intravaginal misoprostol-United States and Canada, 2001-2005. MMWR Morb Mortal Wkly Rep 2005;54:724.
21. Food and Drug Administration. Mifeprex risk evaluation and mitigation strategy. Available at: http://www.fda.gov/downloads/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/UCM258412.pdf. Retrieved November 9, 2014.
22. Raymond EG, Grimes DA. The comparative safety of legal induced abortion and childbirth in the United States. Obstet Gynecol 2012;119:215-9.